Periodontal Disease Treatment Market – Trends Forecast Till 2030

Market Snapshot

Market Overview

The Periodontal Disease Treatment market size was estimated at USD 799.17 million in 2023 and is projected to reach USD 1438.54 million in 2030 at a CAGR of 8.76% during the forecast period 2023-2030.

Periodontal disease treatment typically involves a combination of professional dental cleaning, scaling and root planning to remove plaque and tartar, as well as addressing any underlying issues. In severe cases, surgical procedures might be necessary to reduce pocket depths and promote gum tissue regeneration. Maintaining good oral hygiene and regular dental check-ups are also crucial for managing and preventing periodontal disease.

The growth of the periodontal disease treatment market can be attributed to several factors. The increasing awareness about oral health and the consequences of untreated periodontal disease is driving the demand for treatment options. Moreover, as the global population ages, the prevalence of periodontal diseases tends to increase, leading to a higher demand for the treatment. In addition, technological advancements in dental procedures, including laser therapy and minimally invasive treatments, are improving the effectiveness and patient experience of periodontal disease treatments.

On the other hand, periodontal treatments can be expensive, especially for advanced stages, this can limit access for individuals without adequate insurance coverage. Moreover, dental anxiety and fear of procedures can discourage individuals from seeking treatment, especially when invasive treatments are required. These factors might hamper the growth of the market during forecast period.

The COVID-19 pandemic has had a significant impact on the periodontal dental treatment market. The pandemic led to a decrease in the demand for periodontal dental treatment. This can be attributed to the feat of contracting COVID-19 from aerosolized particles produced during dental procedures. Moreover, the closure and reduced hours of operation of dental practices led to decreased demand for periodontal treatments. Lastly, financial constraints of patients due to job losses and economic recession affected the growth of the market further.

Delvens Industry Expert's Standpoint

The periodontal disease treatment market is expected to grow during the forecast period. This growth can be attributed to various factors. Firstly, there is a growing awareness of the importance of oral health and the role it plays in overall health. Moreover, periodontal diseases are the most common chronic diseases affecting the gums and supporting structures of the teeth. The prevalence of these diseases is increasing due to factors such as poor oral hygiene, smoking, and diabetes. In addition, there are a number of new and innovative treatment technologies being developed for periodontal diseases. These technologies are more effective and less invasive than traditional treatments. However, dental care can be expensive, which can be a barrier to some people seeking treatment. Moreover, in some parts of the world, there is a lack of access to dental care. This due to factors such as poverty, lack of infrastructure, and lack of trained dentists.

Market Portfolio

Key Findings

• Based on type, the market is segmented into gingivitis, chronic periodontal disease, aggressive periodontal disease, others. Gingivitis dominated the market in this segment. This is because gingivitis is one of the most common types of periodontitis. It is usually caused by poor oral hygiene and red, swollen gums. They also tend to bleed easily.
   
• Based on treatment type, the market can be segmented into non-surgical treatment, surgical treatment. Non-surgical treatments dominated the market in this segment. This is because surgical procedures are not often recommended as compared to non-surgical procedures such as systematic antibiotics therapies.
   
• Based on drugs, the market is segmented into systematic antibiotics, local antibiotics. The systematic antibiotics dominated the market in this segment. This can because systematic antibiotics are less invasive than surgery, less painful, and take less time to complete.
   
• Based on route of administration the market is segmented into oral, injectable. The oral route dominated the market in this segment. This is because the oral route is the most common route of administration for periodontal dental treatments as drugs are administered orally in the form of tablets, capsules, or liquids.
   
• Based on End-User, the market is segmented into hospitals, dental clinic, dental academics and research institutes, others.  Dental Clinics dominated the market in this segment as for most of the dental-related problems, people prefer to consult a dentist.
   
• Based on distribution channel, the market is bifurcated into hospital pharmacies, retail pharmacies, others. Hospital pharmacies dominated the market in this segment. This is because most of the drugs used during the periodontal treatments are often available at the dental hospitals.
   
• Based on region, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America. North America is expected to dominate the market in the forecast period. This can be attributed to the presence of major key players, growing initiatives by the local government for the improvement of oral care and provision of knowledgeable dental workforce to address the high unmet needs in this region.

Regional Analysis

North America to Dominate the Market

• North America is estimated to account for the largest market share during the forecast period. This is because of the presence of major key players in the region and growing initiatives by the local government for the improvement of oral care.
   
• Moreover, provision of knowledgeable dental workforce to address the high unmet needs in this region is expected to drive the market during the forecast period.

Competitive Landscape

• 3M
• Bausch Health Companies Inc.
• Biohorizons Implant Systems Inc.
• Colgate-Palmolive Company Limited
• Danaher Corporation
• Den-Mat Holdings LLC
• Dexcel Pharma
• Institut Straumann AG
• Izun Pharmaceuticals
• Kaken Pharmaceutical Co.,Ltd.
• Lyne Laboratories
• Medtronic PLC
• Mylan N.V.
• Noveome Biotherapeutics, Inc
• Pfizer Inc
• Sunstar Suisse S.A
• Tolmar Pharmaceuticals, Inc
• Valeant Pharmaceuticals International Inc.
• WOCKHARDT
• Xttrium Laboratories

Recent Developments

• In April 2023, Novo Nordisk collaborated with Aspect Biosystems, a company involved in bioprinting biomaterials, for the development of bioprinted tissue therapeutics for obesity and diabetes.
   
• In March 2022, Biocomposites signed an agreement with Zimmer Biomet to distribute the new genex Bone Graft Substitute. Genex Bone Graft Substitute is a biphasic composite of exceptional purity specifically formulated to balance osteoconductive scaffold strength and persistence in the body to enable the optimal remodeling of bone architecture.

Reasons to Acquire

• Increase your understanding of the market for identifying the most suitable strategies and decisions based on sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors.
   
• Gain authentic and granular data access for the Periodontal Disease Treatment Market to understand the trends and the factors involved in changing market situations.
   
• Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future.
   
• In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns.

Report Scope